A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches (Q3019496): Difference between revisions
From MaRDI portal
Set profile property. |
Set OpenAlex properties. |
||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1080/02664763.2010.505955 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2028645887 / rank | |||
Normal rank | |||
Revision as of 23:15, 19 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches |
scientific article |
Statements
A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches (English)
0 references
28 July 2011
0 references
dose escalation
0 references
MTD
0 references
Bayesian
0 references
maximum likelihood
0 references
